The World Health Organization has just officially labeled coronavirus COVID-19 a pandemic. Here’s what stocks you should have in your portfolio.
Novan ($NOVN)
Novan uses their proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs. Recently they have received FDA approval for their inhalent based coronavirus clinical trial which is expected to start in April.
iBio ($IBIO)
iBio uses FastPharming which allows them to quickly create or manufacture vaccines using a plant based model for guaranteed efficacy. DARPA has also funded this company for the sole purpose of responding and developing vaccines for coronaviruses like COVID-19.
Aytu Bioscience ($AYTU)
Aytu Bioscience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. Yesterday they have secured an exclusive U.S. distribution agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test.
Test results can be back within 2-5 minutes and can save lots of time.
Co-Diagnostics ($CODX)
Co-diagnostics is a diagnostics company that is currently developing a vaccine and also provides test kits
